Cocrystal Pharma COCP
NASDAQ COCP
$1.18 +0.01 (+0.98%)
As of: Aug 21, 2026 · 10:46 AM EDT

Cocrystal Pharma (COCP) Operating Margin (2010 - 2026)

Cocrystal Pharma (COCP) posted Operating Margin of 1047.11% for Q1 2026, down 264.27% sequentially from 287.45% in Q4 2020.

Cocrystal Pharma (COCP) Operating Margin (2010 - 2026) Analysis & Trends

Cocrystal Pharma has reported Operating Margin for 8 years, with the latest figure at 1047.11% in Q1 2026.

  • Quarterly Operating Margin changed N/A year-over-year to 1047.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 508.1% (changed N/A YoY) and the FY2020 annual result came in at 475.97%, up 26148.0% from the prior year.
  • Operating Margin declined to 1047.11% in Q1 2026 per COCP's latest filing, from 287.45% in the prior quarter.
  • Over five years, Operating Margin peaked at 1047.11% in Q1 2026 and troughed at 1047.11% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Vertex Pharmaceuticals 139.88 Bn 132.03 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 86.62 Bn 78.62 Bn 3.93 Bn 30.15%
3 Argenx Se 65.28 Bn 60.10 Bn 1.37 Bn 32.54%
4 Moderna 61.39 Bn 56.25 Bn 52.00 Mn -562.07%
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.37 Bn 28.06 Bn 992.69 Mn 17.93%
7 BioNTech SE 28.76 Bn 10.37 Bn 668.28 Mn -35.57%
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -0.36%
9 Royalty Pharma 27.24 Bn 26.41 Bn - 19.75%
10 Cocrystal Pharma 16.34 Mn 14.02 Mn - -3,032.38%

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,032.38%
Mar 31, 2026 -1,047.11%
Dec 31, 2020 -287.45%
Sep 30, 2020 -553.99%
Jun 30, 2020 -622.74%
Mar 31, 2020 -425.38%
Dec 31, 2019 -11,921.64%
Sep 30, 2019 -367.48%
Jun 30, 2019 -261.82%
Mar 31, 2019 56.66%
Sep 30, 2015 -14,958.33%
Jun 30, 2015 -14,137.04%
Mar 31, 2015 -8,029.63%
Jun 30, 2013 -37.85%
Mar 31, 2013 -50.27%
Dec 31, 2012 -64.08%
Sep 30, 2012 6.92%
Jun 30, 2012 5.35%
Mar 31, 2012 -16.85%
Dec 31, 2011 -21.30%